🚀 Entrepreneurs and business owners — learn how to revolutionize your employee benefits strategy! In this episode of New to The Street (Ep. 655) airing on Bloomberg, Fox, and YouTube, industry leaders from HILB Group and Health In Tech...

For investors and healthcare innovators, this episode of New to The Street dives deep into NRx Pharmaceuticals' game-changing approach to mental health treatment. CEO Dr. Jonathan Javitt reveals how their reformulated, preservative-free...

Investors and tech enthusiasts — discover how ArriveAI is transforming last-mile logistics with AI, robotics, and smart delivery hubs in this exclusive New to The Street Ep. 655 interview airing on Bloomberg TV. CEO Dan...

Investors, discover how the live music explosion is reshaping markets. David Schulhof, Founder & CEO of the MUSQ ETF, breaks down how his fund taps into the multi-billion-dollar global music industry—from streaming giants like Spotify...

For blockchain investors and tech innovators: In this episode of New to The Street – Exploring the Block (Ep. 670), Pedro Vidal, Chief Relationship Officer at FlowKey, dives into the project’s groundbreaking approach to decentralized...

Investors and entrepreneurs, discover the captivating journey behind one of Manhattan’s most iconic restaurants—Hunt & Fish Club. In New to The Street Ep. 670, co-owner Nelson Braff shares how a passion project grew into a...

Investors and health tech enthusiasts—discover how Vita Bella is redefining personalized medicine. In New to The Street Episode 655, founder Phil Vella joins Jane King to unveil Vita Bella, a revolutionary end-to-end...

Investors, tech innovators, and crypto enthusiasts – don’t miss New to The Street Ep. 659, airing on Bloomberg TV and YouTube. In this episode: 🛠️ FlowKey/Floki’s Pedro Vidal unveils cutting-edge blockchain tools, from DeFi token lockers...

Investors and healthcare innovators—don’t miss this exclusive update from Biovie Inc., a clinical-stage biopharma company developing revolutionary treatments for neurological and neurodegenerative disorders. In New to The...